DIABETIC STATUS OF PEOPLE AFFECTED BY LEPROSY IN DONOROJO LEPROSY RECOVERED VILLAGE: A CROSS SECTIONAL STUDY
DOI:
https://doi.org/10.35473/proheallth.v3i1.805Keywords:
Leprosy, Diabetes Melitus, Impaired Glucose ToleranceAbstract
Just like diabetes, leprosy also cause painless neuropathic ulcers which process is mediated by Schwann-cell. Biochemical changes on leprosy patients presumed to have role on pathogenesis of diabetes mellitus. This study is aimed to know further about diabetic status on population of people affected by leprosy, as the preliminary study to prove the association between diabetes mellitus and leprosy. Data, such as diabetic status, type of leprosy, grade of disability, and other variables are collected from 127 people affected by leprosy in Donorojo leprosy recovered village. Result showed that 19.7% are having diabetes mellitus, and other 23.6% are in pre-diabetic condition. This number is higher than prevalence of diabetes mellitus in Central Java (2.09%) and Indonesia (2%). Thus, we recommend further research on this topic and that all leprosy patients should be routinely screened for diabetes mellitus.
References
Kassa M, Grace J. The Global Burden and Perspectives on Non-communicable Diseases (NCDs) and the Prevention, Data Availability and Systems Approach of NCDs in Low-resource Countries. In: Non-communicable Diseases and Urbanization - A Global Perspective [Working Title] [Internet]. IntechOpen; 2019. p. 13. Available from: https://www.intechopen.com/books/advanced-biometric-technologies/liveness-detection-in-biometrics
WHO. NONCOMMUNICABLE DISEASES. 1st ed. Geneva: WHO; 2018.
Kementerian Kesehatan Republik Indonesia. Infodatin Hari Diabetes Sedunia Tahun 2018. 1st ed. Pusat Data dan Informasi Kementrian Kesehatan RI. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019. 1–8 p.
IDF. IDF Diabetes Atlas 2015 [Internet]. 9th ed. International Diabetes Federation. Brussels: International Diabetes Federation; 2019. 39 p. Available from: http://www.idf.org/about-diabetes/facts-figures
Boulton AJM. Diabetic foot - what can we learn from leprosy? Legacy of Dr Paul W. Brand. Diabetes Metab Res Rev [Internet]. 2012 Feb;28(Suppl 1):3–7. Available from: http://libweb.anglia.ac.uk/
Kumar D, Banerjee D. Diabetes and Leprosy: Are they Related? 2019;3(2):112. Available from: https://www.actascientific.com/ASMS/pdf/ASMS-03-0217.pdf
Saraya MA, Al-Fadhli MA, Qasem JA. Diabetic status of patients with leprosy in Kuwait. J Infect Public Health [Internet]. 2012;5(5):360–5. Available from: http://dx.doi.org/10.1016/j.jiph.2012.08.001
Nigam P, Dayal SG, Srivastava P, Joshi LD, Goyal BM, Dutt B, et al. Diabetic status in leprosy. Hansenol Int. 1979;4(1):7–14.
Butlin CR, Hossain D, Singh S, Warrender T. Diabetes amongst Leprosy-Disabled People in Bangladesh: A Cross-sectional Survey. BIRDEM Med J. 2017;6(2):100–6.
World Health Organization. Global leprosy update, 2018: moving towards a leprosy free world. Wkly Epidemiol Rec [Internet]. 2019;35/36(94):389–412. Available from: https://apps.who.int/iris/bitstream/handle/10665/326775/WER9435-36-en-fr.pdf
World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. WHO. 2006.
Perkumpulan, Endokrinologi, Indonesia, (PERKENI). Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. 2007.
Sugumaran DST. Leprosy Reactions ^ Complications of Steroid Therapy ’. Int J Lepr. 1998;66(I):10–5.
Singh RK, Kumar S, Singh LB. Diabetic Status Among Leprosy Patients in Referral Centres of Bihar and JharKhand in India.
Kemenkes RI. Profil Kesehatan Indonesia 2018, Kementerian Kesehatan RI, Jakarta [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019. 207 p. Available from: https://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2018.pdf
Riset Kesehatan Dasar. Laporan Provinsi Jawa Tengah Riskesdas 2018 [Internet]. 1st ed. Kementerian Kesehatan RI. Semarang; 2018. 88–94 p. Available from: https://dinkesjatengprov.go.id/v2018/storage/2019/12/CETAK-LAPORAN-RISKESDAS-JATENG-2018-ACC-PIMRED.pdf
Suastika K, Dwipayana P, Siswadi M, Tuty RA. Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases. In: Glucose Tolerance [Internet]. InTech; 2012. Available from: http://www.intechopen.com/books/glucose-tolerance/age-is-an-important-risk-factor-for-type-2-diabetes-mellitus-and-cardiovascular-diseases
Beisel WR, Sawyer WD, Ryll ED, Crozier D. Metabolic Effects on Intracellular Infections in Man. Ann Intern Med. 1967;67(4):744–79.
Garg, R; Agrawal, JK; Bajpai, HS; Singh, G; Srivastava P. Glucose Tolerance Test in Leprosy. Indian J opf Lepr. 1990;62(50):4.
Papang R, John AS, Abraham S, Rao P. A study of steroid-induced diabetes mellitus in leprosy A study of steroid-induced diabetes mellitus in leprosy. Indian J opf Lepr. 2009;81(May):125–9.
Ghosh A. A Central India Perspective on Leprosy and Its Association with Diabetes Mellitus. J Soc Heal Diabetes. 2019;07(01):037–8.
Published
Issue
Section
License
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
- Below the abstract, about three to five keywords should appear together with the main body of the article with the font size 11.
- Institutional affiliations, and the email address of the corresponding author should appear only on a detachable cover sheet.
- If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
- Citation is done using bracket (last name and year of publication). When the sources are cited verbatim, page number is included (p. 78 or pp. 78-89).
